Krsnaa Diagnostics (NSE:KRSNAA) Beneish M-Score: -2.62 (As of Jun. 28, 2026)


NSE:KRSNAA Krsnaa Diagnostics Ltd NSE:KRSNAA
71 GF Score
Price ₹538.25
GF Value ₹898.08
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Krsnaa Diagnostics Beneish M-Score?

Krsnaa Diagnostics NSE:KRSNAA +0.13% 71 Beneish M-Score is -2.62 as of Jun. 28, 2026. GuruFocus rates NSE:KRSNAA with a GF Score™ of 71/100 and a GF Value™ of ₹898.08 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Krsnaa Diagnostics ranks better than 53.09% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.62 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Krsnaa Diagnostics's Beneish M-Score or its related term are showing as below:

NSE:KRSNAA' s Beneish M-Score Range Over the Past 10 Years
Min: -2.62   Med: -2.03   Max: -1.37
Current: -2.62

During the past 8 years, the highest Beneish M-Score of Krsnaa Diagnostics was -1.37. The lowest was -2.62. And the median was -2.03.


Krsnaa Diagnostics Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Krsnaa Diagnostics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krsnaa Diagnostics Beneish M-Score Chart

Krsnaa Diagnostics Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial -2.23 -2.14 -1.87 -1.37 -2.62

Krsnaa Diagnostics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.37 0.00 0.00 0.00 -2.62

NSE:KRSNAA vs TMO, DHR, IDXX: Beneish M-Score Comparison

For the Diagnostics & Research subindustry, Krsnaa Diagnostics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krsnaa Diagnostics Beneish M-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Krsnaa Diagnostics's Beneish M-Score falls into.


NSE:KRSNAA
71GF Score
Krsnaa Diagnostics Ltd NSE:KRSNAA
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krsnaa Diagnostics Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Krsnaa Diagnostics for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9114+0.528 * 0.9868+0.404 * 0.8769+0.892 * 1.0775+0.115 * 1.1977
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.022847-0.327 * 1.482
=-2.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹2,955 Mil.
Revenue was ₹7,728 Mil.
Gross Profit was ₹5,320 Mil.
Total Current Assets was ₹7,383 Mil.
Total Assets was ₹18,237 Mil.
Property, Plant and Equipment(Net PPE) was ₹8,597 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹905 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹2,752 Mil.
Long-Term Debt & Capital Lease Obligation was ₹4,683 Mil.
Net Income was ₹1,014 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹1,431 Mil.
Total Receivables was ₹3,009 Mil.
Revenue was ₹7,172 Mil.
Gross Profit was ₹4,872 Mil.
Total Current Assets was ₹4,145 Mil.
Total Assets was ₹12,816 Mil.
Property, Plant and Equipment(Net PPE) was ₹6,863 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹883 Mil.
Selling, General, & Admin. Expense(SGA) was ₹139 Mil.
Total Current Liabilities was ₹3,054 Mil.
Long-Term Debt & Capital Lease Obligation was ₹472 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2955.06 / 7727.74) / (3008.85 / 7171.6)
=0.382396 / 0.419551
=0.9114

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4872.23 / 7171.6) / (5320.21 / 7727.74)
=0.679378 / 0.688456
=0.9868

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (7383.4 + 8596.99) / 18237.16) / (1 - (4144.72 + 6862.75) / 12815.95)
=0.123746 / 0.141112
=0.8769

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=7727.74 / 7171.6
=1.0775

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(883.24 / (883.24 + 6862.75)) / (904.61 / (904.61 + 8596.99))
=0.114025 / 0.095206
=1.1977

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 7727.74) / (139.48 / 7171.6)
=0 / 0.019449
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4682.93 + 2752.01) / 18237.16) / ((471.56 + 3053.88) / 12815.95)
=0.407681 / 0.275082
=1.482

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1014.31 - 0 - 1430.98) / 18237.16
=-0.022847

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Krsnaa Diagnostics has a M-score of -2.62 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.62 mean?
Krsnaa Diagnostics (NSE:KRSNAA) has a Beneish M-Score of -2.62 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Krsnaa Diagnostics and its competitors. According to the industry distribution chart, Krsnaa Diagnostics ranks #91 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 46.9%.
Is Krsnaa Diagnostics' Beneish M-Score too high?
Krsnaa Diagnostics' current Beneish M-Score is -2.62. Based on the distribution chart, Krsnaa Diagnostics ranks #91 out of 194 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Krsnaa Diagnostics has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' Beneish M-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Krsnaa Diagnostics ranks #91 out of 194 companies for Beneish M-Score. This puts Krsnaa Diagnostics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Diagnostics & Research company?
A good Beneish M-Score depends on the Medical Diagnostics & Research industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Krsnaa Diagnostics and its competitors. Krsnaa Diagnostics's current Beneish M-Score is -2.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹898.08, compared to a current price of ₹538.25 — trading 40.1% below its estimated fair value. The current Beneish M-Score is -2.62. Krsnaa Diagnostics' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current Beneish M-Score is -2.62 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?

Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued. The current stock price of ₹538.25 is trading 40.1% below its estimated GF Value™ of ₹898.08. GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.

Key valuation signals for NSE:KRSNAA:

  • Beneish M-Score: -2.62
  • GF Value™: ₹898.08 vs. price of ₹538.25 (40.1% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krsnaa Diagnostics Business Description

Other Exchanges 543328:India
Address S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, Chinchwad, Taluka - Haveli, Pune, MH, IND, 411 019
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
71GF Score

Get the complete analysis for NSE:KRSNAA

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹538.25
Price
₹898.08
GF Value